Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.55 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.54 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.51 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | GCK | P35557 | 1/20 | 0.50 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9967899 | 0.90 | MEN1 (0.57) | MEN1KMT2ANR4A2MAOBNR4A1 | |
| SCHEMBL11122232 | 0.88 | KMT2A (0.56) | MEN1KMT2ANR4A2MAOBNR4A1 | |
| SCHEMBL1438839 | 0.88 | NR4A2 (0.72) | MEN1KMT2ANR4A2MAOBPTPN1 | |
| SCHEMBL41220 | 0.85 | NR4A1 (0.70) | NR4A2MAOBNR4A1NR4A3PTPN1 | |
| SCHEMBL11262742 | 0.85 | MAPT (0.54) | MEN1KMT2ANR4A2MAOBPTPN1 | |
| SCHEMBL13427458 | 0.84 | MEN1 (0.71) | MEN1KMT2ANR4A2MAOBNR4A1 | |
| SCHEMBL10770964 | 0.84 | MEN1 (0.71) | MEN1KMT2ANR4A2MAOBNR4A1 | |
| SCHEMBL1426961 | 0.83 | MEN1 (1.00) | MEN1KMT2ANR4A2MAOBNR4A1 | |
| SCHEMBL7107834 | 0.82 | AR (0.57) | MEN1KMT2ANR4A2MAOBPTPN1 | |
| Hydrochloric Acid SCHEMBL6841086 | 0.81 | MEN1 (0.96) | MEN1KMT2ANR4A2MAOBNR4A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190807-A1 | A METHOD FOR PREPARING R-TERBUTALINE USING CHIRAL AUXILIARY GROUPS | SUZHOU HOMESUN PHARMACEUTICAL CO, LTD. (CN) | 2024-06-13 | — | — | US | claimed |
| EP-4332085-A1 | METHOD FOR PREPARING L-TERBUTALINE BY USING CHIRAL AUXILIARY GROUP | Suzhou Homesun Pharmaceutical Co, Ltd (CN) | 2024-03-06 | — | — | EP | claimed |
| CN-113264839-B | Method for preparing levo-terbutaline by using chiral prosthetic group | 苏州弘森药业股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-110950765-B | Preparation method of terbutaline sulfate | 浙江医药高等专科学校 | 2022-07-12 | — | — | CN | claimed |
| CN-113264839-A | Method for preparing levo-terbutaline by using chiral prosthetic group | 苏州弘森药业股份有限公司 | 2021-08-17 | — | — | CN | claimed |
| CN-112250586-A | Preparation method of terbutaline sulfate and B crystal form thereof | 福安药业集团宁波天衡制药有限公司 | 2021-01-22 | — | — | CN | claimed |
| CN-110950765-A | Preparation method of terbutaline sulfate | 浙江医药高等专科学校 | 2020-04-03 | — | — | CN | claimed |
| US-20240190807-A1 | A METHOD FOR PREPARING R-TERBUTALINE USING CHIRAL AUXILIARY GROUPS | SUZHOU HOMESUN PHARMACEUTICAL CO, LTD. (CN) | 2024-06-13 | — | — | US | disclosed |
| US-20240190807-A1 | A METHOD FOR PREPARING R-TERBUTALINE USING CHIRAL AUXILIARY GROUPS | SUZHOU HOMESUN PHARMACEUTICAL CO, LTD. (CN) | 2024-06-13 | — | — | US | disclosed |
| EP-4332085-A1 | METHOD FOR PREPARING L-TERBUTALINE BY USING CHIRAL AUXILIARY GROUP | Suzhou Homesun Pharmaceutical Co, Ltd (CN) | 2024-03-06 | — | — | EP | disclosed |
| EP-4332085-A1 | METHOD FOR PREPARING L-TERBUTALINE BY USING CHIRAL AUXILIARY GROUP | Suzhou Homesun Pharmaceutical Co, Ltd (CN) | 2024-03-06 | — | — | EP | disclosed |
| CN-110734382-B | Method for synthesizing terbutaline | 苏州弘森药业股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-113995738-B | Application of 2' -halogenated chalcone derivative in preparation of medicine for treating liver related diseases | 中国医学科学院药物研究所 | 2024-02-06 | — | — | CN | disclosed |
| EP-0303465-A2 | Phenethanolamine derivatives | GLAXO GROUP LIMITED (GB) | 1989-02-15 | — | — | EP | disclosed |
| EP-0223410-A2 | Ethanolamine Derivatives | GLAXO GROUP LIMITED (GB) | 1987-05-27 | — | — | EP | disclosed |
| EP-0162576-A1 | Ethanolamine compounds | GLAXO GROUP LIMITED (GB) | 1985-11-27 | — | — | EP | disclosed |
| US-4470997-A | Esters | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-09-11 | — | — | US | disclosed |
| US-4423070-A | DI- AND TRIESTERS OF N-(ACYLAMINOALKYL)-DIHYDROXYPHENYLETHANOLAMINES, ANTIINFLAMMATORY | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1983-12-27 | — | — | US | disclosed |
| US-4021485-A | BRONCHOSPASMOLYTICS, ANTIPRURITICS, ANTIALLERGICS | BOEHRINGER INGELHEIM GMBH (DT) | 1977-05-03 | — | — | US | disclosed |
| US-3966814-A | PERIPHERAL VASODILATORS, ANTIHISTAMINES, SPASMOLYTICS | BOEHRINGER INGELHEIM GMBH (DT) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190807-A1 | A METHOD FOR PREPARING R-TERBUTALINE USING CHIRAL AUXILIARY GROUPS | HBB, TERT, ADRB2 | MEN1 3119/4885KMT2A 2865/4885NR4A2 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.